Transcranial direct current stimulation (tDCS) as an intervention to improve empathic abilities and reduce violent behavior in forensic offenders: study protocol for a randomized controlled trial by Sergiou, C.S. (Carmen) et al.
STUDY PROTOCOL Open Access
Transcranial direct current stimulation
(tDCS) as an intervention to improve
empathic abilities and reduce violent
behavior in forensic offenders: study
protocol for a randomized controlled trial
Carmen S. Sergiou1, Adam J. Woods2, Ingmar H. A. Franken1 and Josanne D. M. van Dongen1*
Abstract
Background: Recent studies show that changes in one of the brain areas related to empathic abilities (i.e. the
ventromedial prefrontal cortex (vmPFC)) plays an important role in violent behavior in abusers of alcohol and
cocaine. According to the models of James Blair, empathy is a potential inhibitor of violent behavior. Individuals
with less empathic abilities may be less susceptible and motivated to inhibit violent behavior, which causes a
higher risk of violence. Recent neuroscientific research shows that modulating (stimulation or inhibition) certain
brain areas could be a promising new intervention for substance abuse and to reduce violent behavior, such as the
neurostimulation technique transcranial direct current stimulation (tDCS). This study aims to investigate tDCS as an
intervention to increase empathic abilities and reduce violent behavior in forensic substance use offenders.
Methods/design: A total sample of 50 male forensic substance abuse patients (25 active and 25 sham stimulation)
will be tested in a double-blind placebo-controlled study, from which half of the patients will receive an active
stimulation plus treatment as usual (TAU) and the other half will receive sham stimulation (placebo) plus TAU. The
patients in the active condition will receive multichannel tDCS targeting the bilateral vmPFC two times a day for 20
min for five consecutive days. Before and after the stimulation period, the patients will complete self-report
measurements, perform the Point Subtraction Aggression Paradigm (PSAP) and a passive viewing empathy task.
Resting state electroencephalography (rsEEG) will be performed before and after the treatment period. A follow up
will be conducted after 6 months. The primary outcome is to investigate multichannel tDCS as a new intervention
to increase empathic abilities and reduce violent behavior in offenders with substance abuse problems. In addition,
we will determine whether electrophysiological responses in the brain are affected by the tDCS intervention. Finally,
the effects of tDCS on reducing craving will be investigated.
Discussion: This study is one of the first studies using multichannel tDCS targeting the vmPFC in a forensic sample.
This study will explore the opportunities to introduce a new intervention to improve empathic abilities and reduce
violence in forensic substance use offenders. Specifically, this study may give insight into how to implement the
tDCS intervention in the setting of daily clinical practice in this complex, multiple-problem target group and with
that contribute to reduction of recidivism.
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Background
Repeatedly using substances has been found to lead to
neuro-adaptations in the ventral striatum and ventral teg-
mental areas and with that, decreased dopamine secretion
[1]. Decreased dopamine secretion leads to a higher crav-
ing for substances and increased saliency for addictive
cues [2–4]. Impaired functioning of the dorsolateral pre-
frontal cortex (DLPFC) in patients with substance abuse
disorders (SUDs) underlies diminished cognitive and in-
hibitory control and increases the tendency to relapse and
maintain addictive behaviors [5–13]. Recent studies show
that changes in the brain areas related to less empathic
ability (i.e. the ventromedial prefrontal cortex (vmPFC)) in
abusers of alcohol and cocaine plays an important role in
violent behavior [14, 15]. Preller and colleagues found in
their study [15] that cocaine users have deficits in emo-
tional empathy and that patients with substance abuse dis-
orders are less emotionally responsive to the emotions of
other individuals and their mental state.
Empathy is crucial for social enhancement, social in-
teractions and relationships, and our emotional and so-
cial life [16]. A deficit in empathic ability could lead to
antisocial and deviant behavior and with that a higher
risk of aggression [15]. Aggression is stated here as be-
havior that is mostly defined by any behavior that is
intended to harm someone who is motivated to avoid
being harmed [17]. As said before, antisocial behavior,
especially aggression, is associated with dysfunctions in
the prefrontal cortex [18–24]. In addition, research has
highlighted the importance of executive functions - the
“higher” cognitive functions that are controlled by the
prefrontal cortex in control of aggression [25–28]. Ac-
cording to the models of James Blair [28–30] violent be-
havior is inhibited by empathy. Individuals with less
empathic abilities may be less susceptible and motivated
to inhibit violent behavior, which increases the risk of
violence.
The role of the prefrontal cortex
Several studies show evidence that impaired prefrontal
cortex areas lead to the emergence of aggressive behavior.
Most notable are impairments in the vmPFC (e.g. emotion
regulation, moral decision-making), and the DLPFC (e.g.
disinhibition and impulsiveness), which is associated with
aggression and violent behavior [25–28]. These dysfunc-
tional prefrontal cortex areas induce psychopathic traits
such as blunted emotions and lack of empathy [31] and
impaired perspective with increased egocentrism and ri-
gidity [19, 32, 33]. Research has found that children with
psychopathic traits have abnormal activity in the vmPFC
during a response-reversal task in comparison to children
without these traits (Finger et al., 2008). In addition, Raine
and colleagues [34, 35] demonstrated the relationship be-
tween violence and empathy and argued that abnormal
brain structure in the vmPFC causes the most extreme
form of empathic inability named “psychopathic predatory
violence”. This psychopathic predatory violence correlates
with the lack of empathy, impaired moral judgment [34],
and hyper metabolism [35] that is associated with in-
creased aggressive impulses.
Figure 1 shows the hypothesized relationship between
the impaired brain areas and the subsequent deficits in
empathy and violent behavior. Although, the DLPFC
modulates the cognitive control and response inhibition
that are associated with aggression and violent behavior
[25–28], in this study we focus on the vmPFC.
Ventromedial prefrontal cortex
The vmPFC is particularly relevant to empathic abilities
and antisocial behavior [29, 36, 37]. Studies using functional
neuroimaging (i.e. functional magnetic resonance imaging
(fMRI)) have shown that neural activity in the vmPFC pre-
dicts empathic abilities and altruistic motivation [38, 39].
Another longitudinal study [19] demonstrated that lesions
damaging the vmPFC, occurring in the first 16 months of
human life, result in lifelong psychopathic antisocial traits
and will also lead to impaired social and moral reasoning.
In addition, damage to the vmPFC is associated with poor
decision-making in antisocial behavior [40, 41].
Furthermore, a recent study [42] combining tDCS with
fMRI demonstrated that anodal tDCS placed on the fore-
head led to increased vmPFC activity and decreased negative
emotions. Taken together, these studies suggest a potential
link between vmPFC functioning and anger regulation.
Transcranial direct current stimulation
tDCS is a non-invasive neuromodulation technique
that modulates the brain region of interest by
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increasing or decreasing neuronal excitability
through constant, low-direct-current electrodes.
tDCS has been proven to be an effective intervention
to modify brain activity [43–45] and has been inves-
tigated in many different disorders [46–48].
In this current study, the effectiveness of tDCS as a
new intervention to increase empathy and reduce violent
behavior in substance abuse offenders will be investi-
gated. Through modulating (stimulating and inhibiting)
certain areas of the brain, tDCS causes a change in the
function of the brain, due to an increase in susceptibility
to generate and facilitate brain-related electrical im-
pulses. This susceptibility is achieved through repeated
sessions of brain stimulation and is thought to produce
long term potentiation (LTP)-like “learning” in stimu-
lated neurons. Functional alterations in the brain due to
long-term substance abuse are hypothesized to improve
with the application of tDCS [49–61] and to reduce
craving.
Several studies showed that emotional processes
can be influenced through anodal tDCS of the pre-
frontal cortex (PFC). tDCS can modulate emotional
pain [62, 63] and enhance empathy to pain [63].
Interestingly, studies [64–66] suggest that anodal
tDCS of the PFC can enhance empathy and increase
the feeling of morality. Although there seems to be a
clear association between empathy and vmPFC func-
tion, only a few studies have investigated modulation
of the vmPFC. Abend and colleagues [67] show in
their study combining tDCS and fMRI that stimulat-
ing with tDCS demonstrated increased emotion-
related activation in the vmPFC. Two studies show
that anodal stimulation of the (right) vmPFC in-
creases empathic ability and morality [66, 67]. Fur-
thermore, the study of Gilam and colleagues [42]
used tDCS simultaneously with fMRI and demon-
strated that activity of the vmPFC was increased
during active compared to sham stimulation.
In addition to empathy, antisocial behavior, including
aggression, is also associated with dysfunctions in the
prefrontal cortex [18–24]. Research shows that studies
targeting the PFC with anodal tDCS can reduce social
exclusion, and the aggressive behavior that emerges from
this exclusion [68] can reduce unprovoked aggressive be-
havior [69] and reduce the intentions of aggressive be-
havior [70, 71]. Based on the aforementioned theory of
Blair linking impaired empathic abilities to violence, and
the model that was demonstrated (Fig. 1), it could be
proposed that the vmPFC plays a crucial role in modu-
lating both empathic abilities and thereby also in violent
behavior. The aforementioned study of Gilam and col-
leagues [42] also demonstrates the relationship between
the vmPFC and violent behavior and shows a decrease
in violent behavior in the first session after active tDCS.
In addition to aberrant functioning of specific brain
areas, recent research [72, 73] also shows that functional
connectivity of brain areas is also affected in individuals
with less empathic abilities. Therefore, it is important
for the evaluation of the effectiveness of a tDCS inter-
vention, to determine how the resting-state connectivity
of the patients, measured with resting state electroen-
cephalography (rsEEG), changes from pre-test to post-
Fig. 1 Relationship between the impaired brain areas, impaired processes and behavior. The highlighted brain area, impaired process and
behavior are discussed in this paper. DLPFC, dorsolateral prefrontal cortex, vmPFC, ventromedial prefrontal cortex
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test with the intervention. Prior research demonstrates
that tDCS can alter functional connectivity and that con-
nectivity change is related to the treatment response (i.e.
effectiveness) [74]. To optimize the intervention and in-
crease current focality we use a newer development of
the original. This technique, called high-definition tDCS
(HD-tDCS or multichannel tDCS) uses gel-based elec-
trodes similar to those used in EEG [75] and is more
precise in targeting the brain area of interest. Therefore,
in this study we will investigate the idea that multichan-
nel tDCS applied over the vmPFC will increase empathic
abilities and subsequently reduce the risk of violence.
Aims of the study
The aim of this study is to investigate the effectiveness
of tDCS in increasing empathy and reducing violent be-
havior in offenders with substance abuse problems.
The following research questions will be addressed in
this study:
1. Does stimulation with multichannel tDCS targeting
the vmPFC increase empathic abilities in forensic
patients with substance abuse problems during an
empathy task from pre intervention to post
intervention?
2. Does stimulation with multichannel tDCS targeting
the vmPFC reduce aggressive response and risk of
violence risk in patients with forensic substance
abuse from pre intervention to post intervention?
3. Does multichannel tDCS targeting the vmPFC
reduce craving in patients with forensic substance
abuse?
4. Does multichannel tDCS targeting the vmPFC
affect electrophysiological response in the brain
measured through EEG from pre intervention to
post intervention?
Outcomes will contribute to the development of more
effective diagnostics and treatment of patients with sub-
stance abuse. Furthermore, these data will potentially
contribute to improving treatment through increasing
understanding of specific targets for treatment interven-
tions. In addition, outcomes may provide better insight
in the functioning of the vmPFC and the relationship be-
tween empathy and risk of violence.
Methods/design
Setting
The study will be carried out in two forensic institutions.
The sample will be recruited from the Forensiche Ver-
slavings Kliniek (FVK), the forensic addiction clinic of
Bouman, Antes. The institution is located in Rotterdam,
The Netherlands. The sample size is based on other
studies; we will operate according to the “Evidence-
based guidelines on the therapeutic use of transcranial
direct current stimulation (tDCS)” published in 2017
[76], and seen as achievable, due to the fact that the ap-
plicant is currently obtaining research at FVK Bouman
Antes, which will make the inclusion of the patients
more feasible.
Procedure/design
In this double blind, placebo-controlled study, a total of
50 male participants between the age of 18 and 60 years
will be randomly assigned to either the active condition
or the sham condition. Eligible participants will be given
written and verbal information about the study and will
be invited to participate. After providing informed con-
sent they will participate at the forensic clinic where they
are admitted and all the data collected will be anonym-
ous and linked to their participant number.
Blinding and randomization
Participants and investigators are blind to the tDCS con-
dition allocation. An external researcher is the only one
who knows which participant number corresponds with
each condition. The principal investigator, the patients
and the research assistants do not know which condition
is being executed. The trial established procedures to
maintain separation in knowledge between the head re-
searcher and the principal investigator. The first author
will randomize the participants before timepoint 0 (T0).
A participant number corresponding with either the ac-
tive condition or the sham condition determines the ran-
dom allocation. In a situation where unblinding is
permissible and to maintain the overall quality and legit-
imacy of the clinical trial, unblinding should occur only
in exceptional circumstances when knowledge of the ac-
tual treatment is absolutely essential for further manage-
ment and safety of the patient according to the Standard
protocol items: recommendation for interventional trials
(SPIRIT) statement [77]. Investigators are encouraged to
discuss this with the Medical Ethical Review Committee
of the Erasmus Medical Center (registration number
2018.065 – NL65209.078.18).
As a standard for effectiveness of the reduction in vio-
lent behavior, the results of a violence risk assessment
instrument the Historical and Clinical Future Risk-
assessment tool (HKT-R) [78] will be assessed before the
intervention starts. During the first session the self-
reported measures will be assessed. EEG will additionally
be performed during a resting-state task and during a
passive-viewing empathy task [73]. The participants will
then perform a rating viewing empathy task [73]. The
patients will perform Point Subtraction Aggression Para-
digm (PSAP) [79] to measure behavioral indices of the
level of aggression.
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After this, a series of ten tDCS sessions (two per day
for five consecutive days) will follow. After every tDCS
session the participants will fill in a questionnaire that
assesses side effects. On Monday, after the last modula-
tion on Friday, the patients will receive a post-
intervention evaluation in which the rsEEG and the tasks
(empathy task and PSAP task) again will be conducted.
As a follow up, risk assessment scores of the participant
will be obtained after 6 months to see whether risk re-
duction is maintained together with one last EEG session
with the PSAP task.
Overview of procedure
The procedures are as follows:
1. Inclusion of patients after informed consent.
2. Collection of information from patients on
diagnosis, substance abuse, demographic
information, and HKT-R.
3. Pre-intervention in which the patients undergo
resting-state EEG (rsEEG) and perform the aggres-
sion task (PSAP) and the empathy task (victims of
aggression). In addition, the patients will fill in the
self-report questionnaires.
4. Intervention multichannel tDCS plus treatment as
usual (TAU) or sham plus TAU: 20 min of anodal
stimulation of the vmPFC and cathodal stimulation
of the left supraorbital area with multichannel
tDCS, two times daily for a period of five
consecutive days.
5. Post-intervention where the patients undergo
rsEEG and will perform the aggression task (PSAP)
and the empathy task (victims of aggression), and
fill out the self-report questionnaires again.
6. Outcome variables: the results of the aggression
task and empathy task and the score on the HKT-R
and the self-report questionnaires will be lower with
respect to the results on the pre-test. Furthermore,
we will investigate whether the functional connect-
ivity (EEG) has changed at the post-test in contrast
to the pre-test and if this differs within the two
conditions (tDCS versus sham).
7. Follow up after 6 months where the patients will
perform the aggression task and the empathy task
one more time and the HKT-R will be
administered.
See Figs. 2 and 3 for a detailed overview of the proced-
ure of the trial.
Multiple studies [80–83] have concluded that activat-
ing the brain state of the area of interest during stimula-
tion, increases the effect of the modulation and
contribute to optimize the intervention. An interesting
study by Nissim and colleagues [84] demonstrated with
fMRI that the optimal gains from using tDCS can be re-
alized by simultaneously using behavior and modulation
to stimulate neural networks. Therefore, to optimize our
intervention and increase the activity of the vmPFC and
the empathic abilities, the participants will be occupied
with tasks and movies that trigger these brain states. On
the first day, the participants will complete the Multifa-
ceted Empathy Task (MET) [85] and the Reading the
Mind in the Eyes test (rMEt) [86], to actively enhance
their perspective and recognition of emotion. When fin-
ished, they will watch the movie “Wonder” (2017) for
the first part of the stimulation week. For the remaining
sessions they will watch the movie “I am Sam” (2001).
The two movies enhance the empathic abilities and per-
spective, and therefore will contribute to the
optimization of brain state.
Sample
A total sample of 50 male patients with forensic sub-
stance abuse (25 active and 25 sham stimulation) will be
tested in a double-blind placebo-controlled study, from
which half of the patients will receive active stimulation
plus TAU and the other half will receive a sham stimula-
tion (placebo) plus TAU.
Inclusion
In order to be eligible to participate in this study, a sub-
ject must meet all of the following criteria: male, age
18–60 years, good understanding of the Dutch language,
diagnosed with an alcohol and/or cocaine SUD
Fig. 2 Flowchart of the trial. rsEEG, resting state electroencephalography, PSAP, Point Subtraction Aggression Paradigm, MET, Multifaceted
Empathy Task, rMET, Reading the Mind in the Eyes Test, T, timepoint
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according to the Diagnostic and statistical manual of
mental disorders 5th edition (DSM-5). The patients have
to be abstinent and have an index offense in violence
category listed in the HKT-R. These criteria have been
selected due to the fact that men show more aggression
on the PSAP task and in general show more violent be-
havior than women.
Exclusion
Subjects meeting any of the following criteria will be
excluded from participation in this study: major
neurological conditions (e.g. traumatic brain injury) or
major mental disorders (i.e. major depression, psych-
otic symptoms). Also, patients taking antipsychotic or
other strong medication cannot participate in the
study.
Recruitment
Recruitment will be active within the forensic institu-
tions. Patients will be actively approached by the PhD
student, or can sign up through a form at the depart-
ment in which they receive their treatment. Research as-
sistants will assist with the assessments. The entire
research team will be trained extensively before they
have an active role in the research.
Fig. 3 Standard protocol items: recommendation for interventional trials (SPIRIT) schedule of enrollment, interventions, and assessments. HKT-R,
Dutch Risk Assessment Tool, PSAP, Point Subtraction Aggression Paradigm, MET, Multifaceted Empathy Task, rMET, Reading the Mind in the Eyes
Test, EEG, electroencephalography TAU, treatment as usual
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After screening for exclusion criteria, the patients will
receive more detailed information about the study and
can decide whether to participate. An informed consent
form will be signed prior to the actual test day.
Conditions
Experimental The patients participating in the active,
experimental condition start on Friday by completing
the aforementioned self-report questionnaires. Also,
EEG will be performed during a resting-state task
(rsEEG) and during the passive viewing empathy task.
After disconnecting the EEG device, participants will
perform the empathy rating task and the PSAP. On
Monday, the participants will start with the tDCS inter-
vention; they will receive 20 min of tDCS two times each
day. There will be a time interval of 3–4 h between the
sessions, depending on the patients’ schedules. This will
last for five consecutive days. One anodal electrode is
placed on the position of Fpz and the other five cathodal
electrodes are placed on AF3, Fz, AF4, F3, F4, according
to the international 10–10 EEG system. The electrodes
used are the Pistim EEG & tDCS hybrid electrodes with
a 12-mm diameter.
Sham The patients participating in the sham condition
will follow exactly the same routine as the participants
in the active condition except they will receive 2mA for
30 s instead of the 20-min stimulation. This has proven
to be effective for blinding as participants habituate to
the sensation of stimulation within seconds of initiation
of the current [87].
tDCS
For the intervention we will operate according to the
Evidence-based guidelines on the therapeutic use of
transcranial direct current stimulation (tDCS) [76].
Multichannel tDCS will be administered with a CE-
certified neurostimulator (StarStim-8, NeuroElectrics)
following the protocol [77]; the device is prepro-
grammed for stimulation with 2 mA for 20min (experi-
mental condition), or with 2 mA for 30 s (sham
condition). We program the device for each participant,
ensuring that the participant and investigator are blinded
to the experimental condition. The experimental treat-
ment is a 20-min tDCS session, two times a day for five
consecutive days (ten sessions per participant). Multi-
channel tDCS will be applied over the vmPFC. The sham
condition is the same as the experimental condition with
the exception that there will only be a ramp up of the
electrical stimulation to mimic the sensation of the
stimulation.
Primary objective The primary objective is to investi-
gate tDCS as a new intervention to increase empathy
and reduce violent behavior in offenders with substance
abuse problems. This will be measured using the results
of the empathy and aggression task from pre-test to
post-test. In addition, we will study whether electro-
physiological responses in the brain are affected by
tDCS; this will be demonstrated through comparing the
EEG from pre-test to post-test. We will use a mixed de-
sign to test whether event-related potential (ERP) ampli-
tudes pre-post intervention differ between the active and
sham group.
Secondary objective(s) The secondary objective is to re-
duce craving in offenders with substance abuse prob-
lems. This will be assessed using the four self-report
measurements on alcohol and drug craving, and to com-
pare the results from pre-test to post-test. Other study
parameters are the results from the self-report question-
naires. These will be compared with the other variables
mentioned before and also compared from pre-test to
post-test.
Instruments
Passive-viewing empathy task To measure empathic
abilities and how it changes between pre and post inter-
vention, patients will participate in a passive-viewing
empathy task. This measurement is based on previous
research [72]. The pictures used in the passive-viewing
task are selected based on ratings conducted through an
anonymous online study (i.e. Amazon’s Mechanical
Turk): 188 individuals participated in this study and
each individual rated 45 pairs of pictures. These were ag-
gression pictures and matched neutral pictures; both
were rated on levels of arousal, aggressiveness, and
valence. The study resulted in 40 pairs of pictures se-
lected for the empathy tasks. The pictures display scenes
with either two men, or one man and one woman aged
between 20 and 25 years old. The men have a white
complexion and the woman has a black skin tone. The
majority of the aggression pictures (99%) had a male
perpetrator and either a male or a female victim. The
scenes involved physical, sexual, and verbal aggression.
To control for stimulus-related confounding factors, all
neutral pictures are carefully matched to the aggressive
pictures. The neutral photographs were identical to the
aggression-related photographs (pair-wise, i.e. the same
persons, same location, same colors, same light), only
without the aggressive action. Three types of pictures
will be used in the experiment: (1) 40 pictures displaying
an interaction between two individuals that is of a vio-
lent tone; (2) 40 pictures displaying an interaction be-
tween two individuals that is neutral, and (3) fifteen
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pictures displaying neutral objects like a bridge or a
lamp (fillers). The fillers will not be used for further ana-
lyses: 95 pictures in total will be randomly presented for
6 s each, with intervals of 1.8 s between the pictures. Par-
ticipants are instructed to look at each picture passively,
because then the automatic neural response in the brain
can be determined [72].
Rating empathy task [72] Following the passive viewing
empathy task, the pictures displaying the neutral and ag-
gressive situations will be presented a second time. Par-
ticipants are now instructed to rate the pictures by
answering four questions. The first question is “Does
this picture give you arousal?”. This is assessed to score
arousal on a 9-point Likert scale (1 = no arousal to 9 =
very high arousal). The following question was to assess
the valence of the picture: “Does this give you a negative
or a positive feeling?” This is assessed on a 9-point
Likert scale (1 = negative emotions, 5 = no emotions, 9 =
positive emotions). The last two questions assess the
measure of state empathy. Last, there are two questions
concerning empathy (i.e. measure of state empathy).
One question assessed to what extent the participant
could empathize with the perpetrator and the other
question assessed to what extent the participants could
empathize with the victim in the aggressive situations.
Both questions will be scored on a 9-point Likert scale
(1 = no empathy to 9 = high empathy). The total em-
pathy task (passive viewing and rating) on average lasts
40 min [71].
The Point Subtraction Aggression Paradigm (PSAP)
Although multiple paradigms are used to measure ag-
gression on an experimental manner in the laboratory,
the PSAP task is known to be one of the best-validated
instruments [88]. During the PSAP task participants play
a game against a (fictive) opponent. The goal of the
game is to earn more points than your opponent. Partic-
ipants are offered 3 choices: (1) participants can earn
points by pressing 100 times on the “1” button on the
keyboard; (2) stealing points from your opponent by
pressing ten times on the “2” button; or (3) guarding
your own points as an escape so the opponent cannot
steal from you by pressing ten times on the “3” button.
When a participant picks option number 2 (aggressive
response), the points that they steal will not add up as
their own score, but will only be subtracted from the
score of the opponent. If the (fictive) opponent is steal-
ing points from the participants, this will be shown in
red letters on the screen; in this way the participant will
be “provoked”. If this provoking leads to the participant
pressing the “2” (stealing) button more frequently, this
can be seen as reactive aggression. When the participant
is not provoked by this event, the aggression can be seen
as proactive aggression. In this study the e-prime version
of the PSAP consists of three 12-min sessions. The out-
come of the PSAP, the aggressive response, is the num-
ber of “2” responses made by the participant. When the
“2” response is a result of the provocation (the fictive
opponent stealing points), then this indicates a reactive
aggression response. If the “2” response is not a reaction
to the provocation, then the reaction will be seen as pro-
active aggression response. Research [88] concludes that
the PSAP has more ecological validity then for example
the Taylor Aggression Paradigm (TAP) [89]. This is due
to the following advantages: first, the PSAP task offers
the participant an option to actively withdraw (pressing
the “3” key), something that is not included in other
paradigm tasks. Second, in the PSAP task the aggressive
response (pressing the “2” button) is not receiving points
and therefore is more ecologically valid then other tasks
that do not have this option. An aggressive reaction is a
cost-benefit consideration, so choosing an option to steal
points that will not add up to your own score for win-
ning could be considered as a costly option.
Self-report questionnaires
Self-Report Psychopathy Scale Short-Form (SRP-SF)
We use the Dutch short version of the SRP-SF [90] in
order to assess psychopathic traits. The SRP-SF consists
of a subset of 29 of the 64 original items and is a self-
report questionnaire in which participants are asked to
rate statements using a 5-point Likert scale. The ques-
tionnaire consists of four subscales: interpersonal ma-
nipulation (manipulation and deception), callous affect
(lack of empathy or regret), instable lifestyle (impulsivity
and sensation-seeking behavior) and criminal behavior
(delinquency and criminal behavior).
Reactive and Proactive Aggression Questionnaire
(RPQ) We use the Dutch version of the RPQ [91] in
order to assess aggression. The RPQ is a 23-item self-
report questionnaire in which the participant has to give
a rating based on how often this behavior has occurred
in the past, on a 3-point scale (“never”, “sometimes”, or
“often”). Next to an overall total aggression score, the
test provides two separate measures of proactive aggres-
sion (deliberate and planned aggression) and reactive ag-
gression (aggression as a reaction to an unplanned
circumstance).
Interpersonal Reactivity Index (IRI) We use the Dutch
version of the IRI [92] in order to assess empathy. This
is a commonly used self-report instrument designed to
assess empathic tendencies. The IRI consists of four sep-
arate subscales: perspective taking (PT), fantasy (FS),
empathic concern (EC), and personal distress (PD).
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Toronto Alexithymia Scale (TAS-20) We use the
Dutch version of the TAS-20 [93] in order to assess
alexithymia. The TAS-20 is a self-report scale compris-
ing 20 items. Each item is rated on a 5-point Likert scale
ranging from 1 (strongly disagree) to 5 (strongly agree).
The TAS20 is a reliable and valid measure of emotion
processing in adults that includes a total score and three
subscales: difficulty identifying feelings (DIF), difficulty
describing feelings (DDF), and externally-oriented think-
ing (EOT).
Risky, Impulsive, and Self-Destructive Behavior
Questionnaire (RISQ) We use the Dutch version of
the RISQ 96] in order to assess risky and impulsive be-
havior. The RISQ is a 38-item self-report questionnaire-
based measure, assessing eight domain-specific factors
(measuring drug use, aggression, self-harm, gambling,
risky sexual behavior, impulsive eating, heavy alcohol
use, and reckless behavior).
Behavioral Impulsivity Scale (BIS-11) [94] We use the
Dutch version of the BIS-11 [94] in order to assess the
personality and behavioral construct of impulsivity. The
BIS-11 is a questionnaire that consists of one of the
three second-order facets of impulsivity. The 30-item
self-report questionnaire consists of six subscales: atten-
tion (i.e. focusing on current tasks), cognitive instability
(i.e. intruding thoughts), motor impulsiveness (i.e. acting
quickly), perseverance (stable lifestyle), cognitive com-
plexity (i.e. enjoys mental challenges), and self-control,
(i.e. plans and thinks deliberatively).
Alcohol Use Disorders Identification Test (AUDIT)
We use the Dutch version of the AUDIT [95] in order
to assess alcohol use. The 10-item AUDIT includes
questions to assess alcohol intake (questions 1–3), alco-
hol dependence (questions 4–6), and alcohol-related
problems (questions 7–10). Questions 1–8 are scored
from 0 to 4, questions 9 and 10 are scored 0, 2, or 4,
resulting in a maximum AUDIT score of 40.
Drug Use Disorder Identification Test (DUDIT) We
use the Dutch version of the DUDIT [96] in order to as-
sess drug use. The DUDIT is an 11-item screening in-
strument to assess non-alcohol drug use patterns and
various drug-related problems. The first nine items are
assessed on a 5-point Likert scale and the last two items
are scored on a 3-point scale. Higher scores suggest
more severe drug problems.
Obsessive Compulsive Drug Use Scale (OC-DUS-
version Cocaine) We use the Dutch version of the OC-
DUS [97] in order to assess drug craving. The OC-DUS
version Cocaine is a 13-item self-report questionnaire
that assesses the inability to control or resist cocaine-
related thoughts and behaviors, frequency and impact of
thoughts and impulses related to cocaine use, and the
degree of interference.
Obsessive Compulsive Drinking Scale (OCDS) We
use the Dutch version of the OCDS [98] in order to as-
sess alcohol craving. The 22-item Dutch version of the
OCDS was developed to reflect obsession and compul-
sivity related to craving and drinking behavior. The
OCDS has been shown to be specific for the obsessive
and compulsive characteristics of drinking-related
thought, urges to drink, and the ability to resist those
thoughts and urges in alcohol-abusing and alcohol-
dependent individuals.
Outcomes
Primary outcomes
The primary outcomes are empathic abilities, aggressive
behavior, and the electrophysiological response in the
brain. Empathic abilities will be measured using the Pas-
sive Viewing Empathy Task [72], followed by the Rating
Empathy Task [72]. The Passive Viewing Empathy task
examines the electrophysiological outcomes of empathic
processing while observing aggressive situations. The re-
sults will be measured in the amplitude of specific ERPs.
The early ERP component resembles the P300, which is
a positive voltage in the latency of 300–650 ms and the
late ERP component reflects the late positive potential
(LPP), a sustained positive potential identified at around
400–1000ms. Specifically, P3 and LPP appear to be a
measure of empathic processing, and therefore make
EEG an adequate tool to indicate any change in em-
pathic abilities, reflected as a change in the amplitude of
the ERPs [73]. In the Rating Empathy Task [72] the pic-
tures displaying the neutral and aggressive situations will
be presented a second time. Participants are now
instructed to rate the pictures by answering four ques-
tions that will result in an outcome in emotional valence,
empathy for the perpetrator, empathy for the victim, and
arousal. The outcome of the self-reported assessment of
empathy is used to measure state empathy.
Aggressive behavior will be assessed using the PSAP
task. The PSAP task is known to be one of the best-
validated instruments in provoking aggression in the
laboratory [88]. In this task the participants will be “pro-
voked” by a (fictive) opponent who will steal points from
them. If the (fictive) opponent is stealing points from the
participants, this will be shown in red letters on the
screen. If this provoking leads to the participant pressing
the “2” (stealing) button more frequently, this can be
seen as reactive aggression. The results of the PSAP task
will be the amount of pressing the “2” button in propor-
tion to the total amount of pressing the buttons.
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As a standard for effectiveness of the reduction of vio-
lent behavior next to the PSAP, the results of a violence
risk assessment instrument (HKT-R) [78] will be
assessed before the intervention starts. The HKT-R is
one of the mandatory risk-assessment tools in forensic
institutions. The clinical, historical, and future indicators
of violent behavior and the risk of recidivism will be
used as the outcome for the reduction of violent
behavior.
Functional brain changes will be measured using
rsEEG, with a resting-state task to measure the baseline
of the brain activity of the participant in a resting-state
condition and the passive viewing empathy task to meas-
ure the electrophysiological changes in brain function
during empathic induction caused by the intervention.
The expectation is that patients who receive tDCS will
show higher event-related potential (ERP) towards the
pictures of the victims after the intervention compared
with patients who have receive the sham condition.
After 6 months, as a standard for effectiveness of the
reduction of violent behavior, the results of the aggres-
sion task (PSAP) and the risk-assessment tool (HKT-R)
will be compared to the results obtained before the
intervention. The HKT-R risk level will be obtained to
see whether there is a longitudinal effect of tDCS on ag-
gression and risk reduction. In addition, to check
whether the effect of the tDCS intervention is long-
lasting, the participants will complete the self-report
questionnaires, the empathy task, and the aggression
task once more.
Secondary outcomes
Beside the primary outcomes, the current study distin-
guishes multiple secondary outcomes. These will be mea-
sured using the self-report questionnaires described in the
'Instruments' section. All the secondary outcomes will be
assessed during T0 and again at T6.
Statistical analysis
Different general linear models (GLM) in SPSS will be
used to analyze the main parameters. For instance, ana-
lyzing the empathy and aggression outcome (empathy
ratings and b responses in the PSAP task), the outcome
variables will be handled as the dependent variables. In
addition, the group variable (active versus sham) will be
used as the independent between-group variable,
whereas the pre-post time will be included as a within-
subject independent variable. A mixed design will be
used in which the pre-post intervention in the experi-
mental group will be compared with the pre-post inter-
vention aggression outcomes in the sham group. The
mixed design will be used for the PSAP outcomes,
empathy ratings, self-report questionnaires, and assess-
ment of risk of violence with the HKT-R instrument.
Power analysis
The sample size is based on the primary outcome and
other studies from the aforementioned guidelines [76]
and seen as achievable. The sample size is based on re-
search [100] that reported large effect sizes (i.e. partial
eta squared 0.25 and 0.21) for the active versus sham
condition, using 15 participants per condition for three
conditions. Because we have two experimental condi-
tions but also include covariates, a sample size of 50
subjects (25 per condition) is considered to have enough
power to detect an effect, when power is set to 80% and
alpha of 5%, two sided.
Discussion
This study protocol describes the design of an interven-
tion with multichannel tDCS targeting bilateral vmPFC
next to TAU, in comparison with the sham condition
and TAU. This study will explore the opportunities to
introduce a new intervention to improve empathy, re-
duce violence, and reduce craving in substance-use
offenders.
The present study has several strengths. First, to our
knowledge only a few studies focus on increasing em-
pathic abilities [62–67, 101] or modulate externalizing
behavior [42, 68–70], but none of the studies focus on
the implication of tDCS in a forensic sample. These indi-
viduals are in need of effective care, and by modulating
the brain activity this can be a first step towards a new
treatment program.
Second, tDCS may also influence substance abuse
[49–61] and, in turn, influence the relationship between
substance abuse and violent behavior. This could lead to
a decrease in recidivism in forensic institutions.
Third, we will use a wide range of instruments and will
gather information through multiple sources. We will
obtain rsEEG, questionnaires about psychopathic traits
(SRP-SF) [90], aggression (RPQ) [91], empathy (IRI)
[92], alexithymia (TAS-20) [93], risky and impulsive be-
havior (RISQ) [99], and impulsivity (BISS11) [94]. For
measuring substance abuse the study includes question-
naires that focus on alcohol use (AUDIT) [95], alcohol
craving (OCDS) [96], drug use (DUDIT) [97], and drug
craving (OC-DUS-version Cocaine) [98]. In addition, we
have the results on the PSAP and empathy task.
Moreover, we will also include the participants who
drop out during the intervention in our 5-day interven-
tion program. This will give insight into the conse-
quences of the formal procedures preceding the
intervention and may eventually enable us to describe
profiles of the intervention with tDCS in treatment suc-
cess and failure.
Finally, this study will contribute to development of a
cheaper and less invasive treatment for substance abuse.
As mentioned before, problems that patients with
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substance abuse bring an enormous burden to the com-
munity (financial and safety). Previous research has
found that substance abuse, especially alcohol and co-
caine, are related to (violent) criminal behavior. Money
invested in treatment may lead to a large reduction in
the costs associated with substance abuse. Nevertheless,
current interventions seem insufficient in the treatment
of substance abuse in forensic mental health care and
are not sufficient enough to reduce the risk of violence
risk; 66% of these patients reoffend.
Despite the strengths of this current study, several
limitations may threaten the quality of our study. The
greatest challenge will be to have an adequate re-
sponse rate at baseline and at the end of the 5-day
treatment. Our target group will be conducted in a
forensic institution and is participation is voluntary,
so the participants can decide to quit at any time.
The population has an extensive history of treatment
and criminal justice, so they might have negative ex-
periences with treatment or research studies. More-
over, the participants already have filled in numerous
questionnaires in their time spent in institutions, such
that they may have become tired or suspicious about
the purpose of the proposed study. To keep the non-
response rate as low as possible, the researchers con-
ducting this study are trained to motivate and
encourage the participants to complete the program.
The interaction will be transparent, attentive, and
flexible and the researchers will be prepared to give
clear information about the purpose, goal, and aim of
the current study at any time. Furthermore, a treat-
ment that uses neurostimulation and EEG might seem
scary and new to the participants as compared to
TAU, so extra explanation might be needed to assure
the participants that it is safe. So, to recruit as many
participants as we aim to in this study will require a
high degree of motivation.
Finally, an active control group (i.e. sham modulation
and TAU) might lead to smaller effect sizes with active
tDCS than when the tDCS treatment is compared to no
treatment or a wait-list group. However, considering the
seriousness of the problems of the forensic substance
use offenders it would not be ethical to let them wait for
an intervention and it remains important to get a sense
of the effects of placebo versus the effects of active
stimulation.
In conclusion, with the present study design we are
able to explore what the added effectiveness is of tDCS
plus TAU in comparison to sham plus TAU, which
could provide valuable information for institutions, re-
searchers, psychologists, and the professionals in the
field of criminal justice. In addition, this study may help
to reduce craving in forensic substance use offenders
and thus reduce not only violent behavior but also
recidivism. The study will contribute to knowledge about
increasing empathic abilities and the functioning of the
vmPFC. Specifically, this study may give insight into
implementing tDCS on the vmPFC in the TAU and the
setting of daily clinical practice in this complex, multiple
problem target group.
Trial status
The current study started in February 2019. The data
collection will run until the 50 participants all completed
the 5-day program. Follow up will be conducted after 6
months to test whether the effects of the intervention
are still present. Until then, the intervention effects are
unknown.
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